Inspire Investing LLC Buys 88,411 Shares of Agilon Health, Inc. $AGL
by Danessa Lincoln · The Markets DailyInspire Investing LLC boosted its stake in Agilon Health, Inc. (NYSE:AGL – Free Report) by 112.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 166,741 shares of the company’s stock after purchasing an additional 88,411 shares during the quarter. Inspire Investing LLC’s holdings in Agilon Health were worth $384,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently modified their holdings of the company. 111 Capital purchased a new position in shares of Agilon Health during the second quarter worth about $36,000. Nisa Investment Advisors LLC grew its holdings in shares of Agilon Health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after purchasing an additional 6,783 shares in the last quarter. Acropolis Investment Management LLC purchased a new position in shares of Agilon Health during the second quarter worth about $44,000. Gabelli Funds LLC purchased a new position in shares of Agilon Health during the first quarter worth about $48,000. Finally, Ridgecrest Wealth Partners LLC purchased a new position in shares of Agilon Health during the first quarter worth about $65,000.
Agilon Health Stock Performance
Shares of AGL stock opened at $0.96 on Friday. Agilon Health, Inc. has a fifty-two week low of $0.71 and a fifty-two week high of $6.08. The stock has a 50 day moving average price of $1.12 and a two-hundred day moving average price of $2.28. The company has a market capitalization of $399.00 million, a P/E ratio of -1.25 and a beta of 0.07.
Agilon Health (NYSE:AGL – Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the previous year, the firm posted ($0.07) EPS. The business’s revenue for the quarter was down 5.9% compared to the same quarter last year. As a group, equities analysts predict that Agilon Health, Inc. will post -0.59 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Jefferies Financial Group cut their price objective on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, October 8th. Barclays cut their price objective on Agilon Health from $3.00 to $1.50 and set an “underweight” rating for the company in a report on Wednesday, August 6th. Benchmark cut their price objective on Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a report on Wednesday, August 6th. Finally, Evercore ISI dropped their target price on Agilon Health from $5.00 to $3.00 and set an “in-line” rating for the company in a research report on Wednesday, July 9th. Four investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $2.81.
Read Our Latest Research Report on Agilon Health
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than Agilon Health
- Using the MarketBeat Stock Split Calculator
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL – Free Report).